Human cytomegalovirus particles directly suppress CD4 T-lymphocyte activation and proliferation

Immunobiology

Volumn 218, Issue 8, 2013, Pages 1034-1040

  Fornara, Olesja ^a   Odeberg, Jenny ^a   Khan, Zahidul ^a   Stragliotto, Giuseppe ^a   Peredo, Inti ^a   Butler, Lynn ^a   Söderberg Nauclér, Cecilia ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CD4 T lymphocytes; Human cytomegalovirus; Inhibition; Supersession; Unresponsiveness

Indexed keywords

CD45RO ANTIGEN; CD69 ANTIGEN; CONCANAVALIN A; GAMMA INTERFERON; GLYCOPROTEIN; GLYCOPROTEIN B; GLYCOPROTEIN H; IMMUNOGLOBULIN; INTERLEUKIN 4; PHORBOL 13 ACETATE 12 MYRISTATE; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; LYMPHOCYTE PROLIFERATION; MEASLES VIRUS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIRUS PARTICLE;

ANTIBODIES, VIRAL; ANTIGENS, CD; ANTIGENS, CD45; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CELL PROLIFERATION; CONCANAVALIN A; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-4; K562 CELLS; LECTINS, C-TYPE; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MACROPHAGES; MEASLES VIRUS; PHYTOHEMAGGLUTININS; TETRADECANOYLPHORBOL ACETATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84878612748     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2013.01.002     Document Type: Article

References (31)

1. Ahlfors K. IgG antibodies to cytomegalovirus in a normal urban Swedish population. Scand. J. Infect. Dis. 1984, 16(4):335-337.
2. Appay V., Dunbar P.R., et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 2002, 8(4):379-385.
3. Cheung K.S., Li J.K., et al. Murine cytomegalovirus infection: hematological, morphological, and functional study of lymphoid cells. Infect. Immun. 1981, 33(1):239-249.
4. Cobbs C.S., Harkins L., et al. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res. 2002, 62(12):3347-3350.
5. Gabaev I., Steinbruck L., et al. The human cytomegalovirus UL11 protein interacts with the receptor tyrosine phosphatase CD45, resulting in functional paralysis of T cells. PLoS Pathog. 2011, 7(12):e1002432.
6. Gredmark S., Tilburgs T., et al. Human cytomegalovirus inhibits cytokine-induced macrophage differentiation. J. Virol. 2004, 78:10378-10389.
7. Gredmark S., Soderberg-Naucler C. Human cytomegalovirus inhibits differentiation of monocytes into dendritic cells with the consequence of depressed immunological functions. J. Virol. 2003, 77:10943-10956.
8. Harkins L., Volk A.L., et al. Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet 2002, 360(9345):1557-1563.
9. Hegde N.R., Tomazin R.A., et al. Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation. J. Virol. 2002, 76(21):10929-10941.
10. Jackson S.E., Mason G.M., et al. Human cytomegalovirus immunity and immune evasion. Virus Res. 2011, 157(2):151-160.
11. Le Roy E., Muhlethaler-Mottet A., et al. Escape of human cytomegalovirus from HLA-DR-restricted CD4(+) T-cell response is mediated by repression of gamma interferon-induced class II transactivator expression. J. Virol. 1999, 73(8):6582-6589.
12. Loewendorf A.I., Steinbrueck L., et al. The mouse cytomegalovirus glycoprotein m155 inhibits CD40 expression and restricts CD4 T cell responses. J. Virol. 2011, 85(10):5208-5212.
13. Lucin P., Pavic I., et al. Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands. J. Virol. 1992, 66(4):1977-1984.
14. Miller D.M., Cebulla C.M., et al. Human cytomegalovirus inhibition of major histocompatibility complex transcription and interferon signal transduction. Curr. Top. Microbiol. Immunol. 2002, 269:153-170.
15. Moutaftsi M., Mehl A.M., et al. Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells. Blood 2002, 99(8):2913-2921.
16. Nichols W.G., Corey L., et al. High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection. J. Infect. Dis. 2002, 185(3):273-282.
17. Odeberg J., Soderberg-Naucler C. Reduced expression of HLA class II molecules and Iinterleukin-10- and transforming growth factor beta1-independent suppression of T-cell proliferation in human cytomegalovirus-infected macrophage cultures. J. Virol. 2001, 75(11):5174-5181.
18. Odeberg J., Plachter B., et al. Human cytomegalovirus protein pp65 mediates accumulation of HLA-DR in lysosomes and destruction of the HLA-DR alpha-chain. Blood 2003, 101(12):4870-4877.
19. Ragazzo J.L., Ozaki M.E., et al. Costimulation via lymphocyte function-associated antigen 1 in the absence of CD28 ligation promotes anergy of naive CD4+ T cells. Proc. Natl. Acad. Sci. U. S. A. 2001, 98(1):241-246.
20. Reusser P., Riddell S.R., et al. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 1991, 78(5):1373-1380.
21. Rice G.P., Schrier R.D., et al. Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products. Proc. Natl. Acad. Sci. U. S. A. 1984, 81(19):6134-6138.
22. Samanta M., Harkins L., et al. High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma. J. Urol. 2003, 170(3):998-1002.
23. Selgrade M.K., Ahmed A., et al. Effect of murine cytomegalovirus on the in vitro responses of T and B cells to mitogens. J. Immunol. 1976, 116(5):1459-1465.
24. Senechal B., Boruchov A.M., et al. Infection of mature monocyte-derived dendritic cells with human cytomegalovirus inhibits stimulation of T-cell proliferation via the release of soluble CD83. Blood 2004, 103(11):4207-4215.
25. Soderberg C., Larsson S., et al. Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection. J. Virol. 1993, 67(6):3166-3175.
26. Soderberg-Naucler C., Fish K.N., et al. Interferon-gamma and tumor necrosis factor-alpha specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines. J. Clin. Invest. 1997, 100(12):3154-3163.
27. Spencer J.V., Lockridge K.M., et al. Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. J. Virol. 2002, 76(3):1285-1292.
28. Tomazin R., Boname J., et al. Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells. Nat. Med. 1999, 5(9):1039-1043.
29. van Leeuwen E.M., Remmerswaal E.B., et al. Emergence of a CD4+CD28- granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection. J. Immunol. 2004, 173(3):1834-1841.
30. Walter E.A., Greenberg P.D., et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. New Engl. J. Med. 1995, 333:1038-1044.
31. Wentworth B.B., French L. Plaque assay of cytomegalovirus strains of human origin. Proc. Soc. Exp. Biol. Med. 1970, 135(2):253-258.